Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06562 | 32824383 | Cancers (Basel) | Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis. | 2020 | Details |
| A06563 | 32824349 | Antioxidants (Basel) | Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06564 | 32824337 | Int J Mol Sci | History of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06565 | 32824277 | Int J Mol Sci | Lactobacillus Strains Alleviated Hyperlipidemia and Liver Steatosis in Aging Rats via Activation of AMPK. | 2020 | Details |
| A06566 | 32824177 | Nutrients | Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review. | 2020 | Details |
| A06567 | 32823983 | J Clin Med | Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. | 2020 | Details |
| A06568 | 32823659 | Int J Mol Sci | Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH. | 2020 | Details |
| A06569 | 32823621 | Nutrients | Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease-A Meta-Analysis. | 2020 | Details |
| A06570 | 32823613 | Nutrients | Ethyl Acetate Fraction of Amomum xanthioides Ameliorates Nonalcoholic Fatty Liver Disease in a High-Fat Diet Mouse Model. | 2020 | Details |
| A06571 | 32823604 | J Clin Med | Trends in the Prevalence of Non-Alcoholic Fatty Liver Disease and Its Future Predictions in Korean Men, 1998-2035. | 2020 | Details |
| A06572 | 32822391 | PLoS One | Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus. | 2020 | Details |
| A06573 | 32822325 | Orv Hetil | The potential role of organic and conventional yoghurt consumption in the treatment of non-alcoholic fatty liver disease | 2020 | Details |
| A06574 | 32822324 | Orv Hetil | Fat rich diet-induced steatosis and changes in the gut–liver axis | 2020 | Details |
| A06575 | 32822323 | Orv Hetil | New aspects of the development of liver diseases – with special regard to the role of autophagy and microRNA | 2020 | Details |
| A06576 | 32822095 | J Magn Reson Imaging | Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06577 | 32821738 | J Lipid Atheroscler | Hepatic Expression of the Serine Palmitoyltransferase Subunit Sptlc2 Reduces Lipid Droplets in the Liver by Activating VLDL Secretion. | 2020 | Details |
| A06578 | 32821721 | J Lipid Atheroscler | Ceramides: Nutrient Signals that Drive Hepatosteatosis. | 2019 | Details |
| A06579 | 32821351 | Gastroenterol Hepatol Bed Bench | A cost of illness analysis of hepatocellular carcinoma for the Greek healthcare setting. | 2020 | Details |
| A06580 | 32821336 | World J Hepatol | Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study. | 2020 | Details |
| A06581 | 32821071 | World J Gastroenterol | Helicobacter pylori infection: Beyond gastric manifestations. | 2020 | Details |
| A06582 | 32821068 | World J Gastroenterol | Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge. | 2020 | Details |
| A06585 | 32819571 | Biochem Biophys Res Commun | Secreted phosphoglucose isomerase is a novel biomarker of nonalcoholic fatty liver in mice and humans. | 2020 | Details |
| A06586 | 32819566 | Biochem Biophys Res Commun | Genetic ablation of Fas-activated serine/threonine kinase ameliorates obesity-related hepatic glucose and lipid metabolic disorders via sirtuin-1 signaling. | 2020 | Details |
| A06587 | 32819262 | Curr Drug Saf | Efficacy and Cardiovascular Safety of DPP-4 Inhibitors. | 2021 | Details |
| A06588 | 32818571 | J Hepatol | miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder. | 2020 | Details |
| A06589 | 32818435 | Cell Metab | Triose Kinase Controls the Lipogenic Potential of Fructose and Dietary Tolerance. | 2020 | Details |
| A06590 | 32816619 | Gut Microbes | Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease. | 2020 | Details |
| A06591 | 32816363 | FASEB J | Identification of CYP46A1 as a new regulator of lipid metabolism through CRISPR-based whole-genome screening. | 2020 | Details |
| A06592 | 32815965 | Food Funct | A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts. | 2020 | Details |
| A06593 | 32815873 | J Clin Gastroenterol | Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases. | 2021 | Details |
| A06594 | 32814993 | Curr Gastroenterol Rep | Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06596 | 32813194 | Hepatol Int | Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study. | 2020 | Details |
| A06597 | 32812944 | Metabol Open | Regulation of hepatic genes related to lipid metabolism and antioxidant enzymes by sodium butyrate supplementation. | 2020 | Details |
| A06598 | 32812930 | Metabol Open | PIN1, a perspective on genetic biomarker for nonalcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A06599 | 32812776 | Am J Physiol Gastrointest Liver Physiol | An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase. | 2020 | Details |
| A06600 | 32812775 | Am J Physiol Gastrointest Liver Physiol | Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity. | 2020 | Details |
| A06601 | 32812688 | Pediatr Diabetes | Effects of fatty liver on the size and composition of high-density lipoprotein cholesterol subpopulations in adolescents with type 2 diabetes mellitus. | 2020 | Details |
| A06602 | 32811452 | BMC Med Genet | Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis. | 2020 | Details |
| A06603 | 32811209 | Expert Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications. | 2020 | Details |
| A06604 | 32810900 | Liver Int | Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease. | 2020 | Details |
| A06605 | 32810797 | J Nutr Biochem | A combined healthy strategy for successful weight loss, weight maintenance and improvement of hepatic lipid metabolism. | 2020 | Details |
| A06606 | 32810635 | Free Radic Biol Med | Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease. | 2020 | Details |
| A06607 | 32810590 | Food Chem Toxicol | Transcript and protein marker patterns for the identification of steatotic compounds in human HepaRG cells. | 2020 | Details |
| A06608 | 32810487 | Metabolism | Revealing the role of peroxisome proliferator-activated receptor β/δ in nonalcoholic fatty liver disease. | 2020 | Details |
| A06609 | 32810309 | J Gastroenterol Hepatol | Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06610 | 32809954 | J Pediatr Endocrinol Metab | Importance of thyroid-stimulating hormone levels in liver disease. | 2020 | Details |
| A06611 | 32809824 | J Med Chem | Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting. | 2020 | Details |
| A06612 | 32808824 | Can J Physiol Pharmacol | Intricacies of the endothelin system in human obesity: role in the development of complications and potential as a therapeutic target. | 2020 | Details |
| A06613 | 32808114 | J Physiol Biochem | Potential roles of bone morphogenetic protein-9 in glucose and lipid homeostasis. | 2020 | Details |
| A06614 | 32808060 | Eur J Nutr | Betaine prevented high-fat diet-induced NAFLD by regulating the FGF10/AMPK signaling pathway in ApoE-/- mice. | 2020 | Details |
| A06615 | 32807638 | Nutr Metab Cardiovasc Dis | Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06617 | 32807146 | BMC Complement Med Ther | Regulation effects of total flavonoids in Morus alba L. on hepatic cholesterol disorders in orotic acid induced NAFLD rats. | 2020 | Details |
| A06618 | 32805401 | Free Radic Biol Med | Cyanidin-3-O-β-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1/NF-κB signaling pathway. | 2020 | Details |
| A06619 | 32805210 | Chem Biol Interact | High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. | 2020 | Details |
| A06621 | 32805205 | Lancet Gastroenterol Hepatol | Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial. | 2020 | Details |
| A06622 | 32804855 | Eur J Gastroenterol Hepatol | Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. | 2021 | Details |
| A06623 | 32803716 | Indian J Gastroenterol | Poor outcomes in patients with cirrhosis and Corona Virus Disease-19. | 2020 | Details |
| A06624 | 32803141 | Cardiovasc Endocrinol Metab | Nonalcoholic fatty liver disease: implications for endocrinologists and cardiologists. | 2020 | Details |
| A06625 | 32802885 | Biomed Res Int | Protective Effects of MitoTEMPO on Nonalcoholic Fatty Liver Disease via Regulating Myeloid-Derived Suppressor Cells and Inflammation in Mice. | 2020 | Details |
| A06626 | 32802809 | J Hepatocell Carcinoma | Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes. | 2020 | Details |
| A06627 | 32801462 | J Clin Biochem Nutr | Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids. | 2020 | Details |
| A06628 | 32801031 | J Nutr Biochem | Anti-inflammatory activities of green tea catechins along the gut-liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies. | 2020 | Details |
| A06629 | 32801014 | Clin Gastroenterol Hepatol | Associations Between Reproductive and Hormone-Related Factors and Risk of Nonalcoholic Fatty Liver Disease in a Multiethnic Population. | 2020 | Details |
| A06630 | 32801011 | Clin Gastroenterol Hepatol | Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018. | 2020 | Details |
| A06631 | 32800834 | Life Sci | High fructose intake and the route towards cardiometabolic diseases. | 2020 | Details |
| A06633 | 32800550 | Biochem Biophys Res Commun | Metformin, resveratrol, and exendin-4 inhibit high phosphate-induced vascular calcification via AMPK-RANKL signaling. | 2020 | Details |
| A06634 | 32799936 | Br J Nutr | Association between consumption frequency of honey and non-alcoholic fatty liver disease: results from a cross-sectional analysis based on the Tianjin Chronic Low-grade Systemic Inflammation and Health (TCLSIH) Cohort Study. | 2020 | Details |
| A06635 | 32799832 | BMC Cancer | Quantified MRI and 25OH-VitD3 can be used as effective biomarkers for patients with neoadjuvant chemotherapy-induced liver injury in CRCLM? | 2020 | Details |
| A06636 | 32799384 | Liver Int | Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06637 | 32798709 | Clin Gastroenterol Hepatol | Effects of Metformin Exposure on Survival in a Large National Cohort of Patients With Diabetes and Cirrhosis. | 2020 | Details |
| A06638 | 32798334 | Immun Inflamm Dis | Cannabinoid receptor type 1 antagonist inhibits progression of obesity-associated nonalcoholic steatohepatitis in a mouse model by remodulating immune system disturbances. | 2020 | Details |
| A06639 | 32798261 | Phytother Res | The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double-blind randomized clinical trial. | 2020 | Details |
| A06640 | 32798017 | Biochem Biophys Res Commun | GPR91 antagonist and TGF-β inhibitor suppressed collagen production of high glucose and succinate induced HSC activation. | 2020 | Details |
| A06641 | 32797346 | Dig Dis Sci | Racial and Socioeconomic Disparities in Hospitalization of Pediatrics with Liver Disease from 2005 to 2015. | 2020 | Details |
| A06643 | 32796650 | Metabolites | Metabolic Profiling Reveals Aggravated Non-Alcoholic Steatohepatitis in High-Fat High-Cholesterol Diet-Fed Apolipoprotein E-Deficient Mice Lacking Ron Receptor Signaling. | 2020 | Details |
| A06644 | 32796353 | Eur J Gastroenterol Hepatol | A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis. | 2021 | Details |
| A06645 | 32796047 | J Epidemiol Community Health | Fruit and vegetable consumption and non-alcoholic fatty liver disease among Korean adults: a prospective cohort study. | 2020 | Details |
| A06646 | 32795560 | Metabolism | Perturbation of the circadian clock and pathogenesis of NAFLD. | 2020 | Details |
| A06647 | 32795504 | Ageing Res Rev | Structure-functional implications of longevity protein p66Shc in health and disease. | 2020 | Details |
| A06649 | 32795119 | Metab Syndr Relat Disord | Omeprazole and Spirulina Platensis Ameliorate Steatohepatitis in Experimental Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06651 | 32794259 | Hepatology | The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in NASH. | 2020 | Details |
| A06652 | 32793612 | Front Med (Lausanne) | FIB-4 Regression With Direct-Acting Antiviral Therapy in Patients With Hepatitis C Infection: A Safety-Net Hospital Experience. | 2020 | Details |
| A06653 | 32792584 | Sci Rep | Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity. | 2020 | Details |
| A06654 | 32791802 | Zhonghua Gan Zang Bing Za Zhi | [Research progress of non-alcoholic fatty liver disease in postmenopausal women]. | 2020 | Details |
| A06655 | 32791796 | Zhonghua Gan Zang Bing Za Zhi | [A cohort study on the correlation between body mass index trajectories and new-onset non-alcoholic fatty liver disease]. | 2020 | Details |
| A06656 | 32791795 | Zhonghua Gan Zang Bing Za Zhi | [Construction of transmembrane 6 superfamily member 2 E167K gene knock-in mouse model by using CRISPR/Cas9 technology]. | 2020 | Details |
| A06657 | 32791791 | Zhonghua Gan Zang Bing Za Zhi | [Diagnostic value of liver stiffness measurement for the evaluation of liver fibrosis in nonalcoholic fatty liver]. | 2020 | Details |
| A06658 | 32791578 | Clin Mol Hepatol | Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease. | 2020 | Details |
| A06659 | 32791402 | Eur J Med Chem | Synthesis of natural 3'-Prenylchalconaringenin and biological evaluation of ameliorating non-alcoholic fatty liver disease and metabolic syndrome. | 2020 | Details |
| A06660 | 32791310 | Diabetes Metab | Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes. | 2020 | Details |
| A06661 | 32791115 | Cell Host Microbe | Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future. | 2020 | Details |
| A06662 | 32790863 | Endocrinology | DPP-4 Inhibition with Anagliptin Reduces Lipotoxicity-Induced Insulin Resistance and Steatohepatitis in Male Mice. | 2020 | Details |
| A06663 | 32790577 | Physiol Rev | Molecular Physiology of Bile Acid Signaling in Health, Disease, and Aging. | 2020 | Details |
| A06664 | 32789149 | Clin Nutr Res | The Association between Nuts Intake and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: a Case-Control Study. | 2020 | Details |
| A06665 | 32789148 | Clin Nutr Res | Association between Inflammatory Biomarkers and Nutritional Status in Fatty Liver. | 2020 | Details |
| A06666 | 32788910 | EXCLI J | Octyl gallate induces hepatic steatosis in HepG2 cells through the regulation of SREBP-1c and PPAR-gamma gene expression. | 2020 | Details |
| A06667 | 32788075 | Surg Obes Relat Dis | Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy. | 2020 | Details |
| A06668 | 32786869 | J Agric Food Chem | Combined Effect of Quercetin and Fish Oil on Oxidative Stress in the Liver of Mice Fed a Western-Style Diet. | 2020 | Details |
| A06669 | 32786868 | J Agric Food Chem | Fermented Soy Paste Alleviates Lipid Accumulation in the Liver by Regulating the AMPK Pathway and Modulating Gut Microbiota in High-Fat-Diet-Fed Rats. | 2020 | Details |
| A06670 | 32786176 | Zool Res | Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models. | 2020 | Details |